Cancer causes metabolic perturbations associated with reduced insulin-stimulated glucose uptake in peripheral tissues and impaired muscle microvascular perfusion.

[1]  M. Tschöp,et al.  Glucometabolic consequences of acute and prolonged inhibition of fatty acid oxidation. , 2020, Journal of lipid research.

[2]  J. Szemraj,et al.  Role of PI3K/AKT Pathway in Insulin-Mediated Glucose Uptake , 2018, Blood Glucose Levels.

[3]  Felipe Henriques,et al.  Adipose Tissue Remodeling during Cancer Cachexia , 2018, Muscle Cells - Recent Advances and Future Perspectives.

[4]  H. Weir,et al.  Trends in cancer mortality among people with vs without diabetes in the USA, 1988–2015 , 2019, Diabetologia.

[5]  J. Zierath,et al.  Voluntary wheel running in the late dark phase ameliorates diet-induced obesity in mice without altering insulin action. , 2019, Journal of applied physiology.

[6]  J. Nielsen,et al.  Chemical denervation using botulinum toxin increases Akt expression and reduces submaximal insulin-stimulated glucose transport in mouse muscle. , 2019, Cellular signalling.

[7]  Ajit S. Divakaruni,et al.  Etomoxir Inhibits Macrophage Polarization by Disrupting CoA Homeostasis. , 2018, Cell metabolism.

[8]  Guihua Liu,et al.  The PI3K/AKT pathway in obesity and type 2 diabetes , 2018, International journal of biological sciences.

[9]  D. James,et al.  Muscle and adipose tissue insulin resistance: malady without mechanism? , 2018, Journal of Lipid Research.

[10]  E. Meylan,et al.  Glucose transporters in cancer – from tumor cells to the tumor microenvironment , 2018, The FEBS journal.

[11]  E. Richter,et al.  Rac1 muscle knockout exacerbates the detrimental effect of high‐fat diet on insulin‐stimulated muscle glucose uptake independently of Akt , 2018, The Journal of physiology.

[12]  J. Zierath,et al.  Effects of high-fat diet and AMP-activated protein kinase modulation on the regulation of whole-body lipid metabolism , 2018, Journal of Lipid Research.

[13]  E. Choi,et al.  Enhancement of cellular glucose uptake by reactive species: a promising approach for diabetes therapy , 2018, RSC advances.

[14]  M. Korc,et al.  Cancer-associated cachexia , 2018, Nature Reviews Disease Primers.

[15]  Thomas E. Nichols,et al.  HHS Public Access , 2018 .

[16]  A. Longatto-Filho,et al.  High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer , 2017, PloS one.

[17]  A. Guilherme,et al.  Early suppression of adipocyte lipid turnover induces immunometabolic modulation in cancer cachexia syndrome , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  D. Fazakerley,et al.  Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration , 2017, Cancer & metabolism.

[19]  C. Kolka.  The Skeletal Muscle Microvasculature and Its Effects on Metabolism , 2016 .

[20]  A. Klip,et al.  Rac1 governs exercise‐stimulated glucose uptake in skeletal muscle through regulation of GLUT4 translocation in mice , 2016, The Journal of physiology.

[21]  A. Boschero,et al.  Acute exercise restores insulin clearance in diet-induced obese mice. , 2016, The Journal of endocrinology.

[22]  Rosmin Elsa Mohan,et al.  Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia , 2016, Nature Medicine.

[23]  Q. Wang,et al.  Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer , 2016, Cell Death and Disease.

[24]  M. Keske,et al.  Muscle microvascular blood flow responses in insulin resistance and ageing , 2016, The Journal of physiology.

[25]  D. Wilkinson,et al.  The effects of resistance exercise training on macro‐ and micro‐circulatory responses to feeding and skeletal muscle protein anabolism in older men , 2015, The Journal of physiology.

[26]  Erwin F. Wagner,et al.  Cancer metabolism: A waste of insulin interference , 2015, Nature.

[27]  D. Bilder,et al.  Malignant Drosophila tumors interrupt insulin signaling to induce cachexia-like wasting. , 2015, Developmental cell.

[28]  N. Perrimon,et al.  Systemic organ wasting induced by localized expression of the secreted insulin/IGF antagonist ImpL2. , 2015, Developmental cell.

[29]  P. Zhang,et al.  Local Tumor Control and Normal Tissue Toxicity of Pulsed Low-Dose Rate Radiotherapy for Recurrent Lung Cancer , 2015, Dose-response : a publication of International Hormesis Society.

[30]  K. Petersen,et al.  Hepatic Acetyl CoA Links Adipose Tissue Inflammation to Hepatic Insulin Resistance and Type 2 Diabetes , 2015, Cell.

[31]  G. Cline,et al.  Functional polarization of tumour-associated macrophages by tumour-derived lactic acid , 2014, Nature.

[32]  S. Friis,et al.  Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment , 2014, Diabetologia.

[33]  R. Taschereau,et al.  The hidden cost of housing practices: using noninvasive imaging to quantify the metabolic demands of chronic cold stress of laboratory mice. , 2013, Comparative medicine.

[34]  M. Keske,et al.  Muscle insulin resistance resulting from impaired microvascular insulin sensitivity in Sprague Dawley rats. , 2013, Cardiovascular research.

[35]  D. Wasserman,et al.  Muscle-Specific Vascular Endothelial Growth Factor Deletion Induces Muscle Capillary Rarefaction Creating Muscle Insulin Resistance , 2013, Diabetes.

[36]  S. Rosen,et al.  Glucose transporters in cancer metabolism , 2012, Current opinion in oncology.

[37]  L. Goodyear,et al.  Exercise Alleviates Lipid-Induced Insulin Resistance in Human Skeletal Muscle–Signaling Interaction at the Level of TBC1 Domain Family Member 4 , 2012, Diabetes.

[38]  E. Barrett,et al.  Insulin‐Induced Microvascular Recruitment in Skin and Muscle are Related and Both are Associated with Whole‐Body Glucose Uptake , 2012, Microcirculation.

[39]  S. Klein,et al.  Relationship between adipose tissue lipolytic activity and skeletal muscle insulin resistance in nondiabetic women. , 2012, The Journal of clinical endocrinology and metabolism.

[40]  K. Kendler,et al.  The dappled nature of causes of psychiatric illness: replacing the organic–functional/hardware–software dichotomy with empirically based pluralism , 2012, Molecular Psychiatry.

[41]  R. Hamanaka,et al.  Targeting glucose metabolism for cancer therapy , 2012, The Journal of experimental medicine.

[42]  R. Goswami,et al.  Prevalence and significance of NALP5 autoantibodies in patients with idiopathic hypoparathyroidism. , 2012, The Journal of clinical endocrinology and metabolism.

[43]  C. Stehouwer,et al.  Microvascular Dysfunction: A Potential Mechanism in the Pathogenesis of Obesity‐associated Insulin Resistance and Hypertension , 2012, Microcirculation.

[44]  K. Kinzig,et al.  The role of insulin resistance in the development of muscle wasting during cancer cachexia , 2011, Journal of cachexia, sarcopenia and muscle.

[45]  S. Chevalier,et al.  Normal protein anabolic response to hyperaminoacidemia in insulin‐resistant patients with lung cancer cachexia , 2011, Clinical nutrition.

[46]  S. B. Peres,et al.  Adipose tissue inflammation and cancer cachexia: possible role of nuclear transcription factors. , 2012, Cytokine.

[47]  Shoji Mano,et al.  Gateway Vectors for Plant Genetic Engineering: Overview of Plant Vectors, Application for Bimolecular Fluorescence Complementation (BiFC) and Multigene Construction , 2012 .

[48]  M. Manchester,et al.  Inhibition of fatty acid metabolism ameliorates disease activity in an animal model of multiple sclerosis , 2011, Scientific reports.

[49]  Clemens Diwoky,et al.  Adipose Triglyceride Lipase Contributes to Cancer-Associated Cachexia , 2011, Science.

[50]  P. Arner.  Lipases in Cachexia , 2011, Science.

[51]  E. Richter,et al.  A new method to study changes in microvascular blood volume in muscle and adipose tissue: real-time imaging in humans and rat. , 2011, American journal of physiology. Heart and circulatory physiology.

[52]  C. Welinder,et al.  Coomassie staining as loading control in Western blot analysis. , 2011, Journal of proteome research.

[53]  E. Barrett,et al.  Free fatty acids induce insulin resistance in both cardiac and skeletal muscle microvasculature in humans. , 2011, The Journal of clinical endocrinology and metabolism.

[54]  H. Pilegaard,et al.  Lipid-Induced Insulin Resistance Affects Women Less Than Men and Is Not Accompanied by Inflammation or Impaired Proximal Insulin Signaling , 2010, Diabetes.

[55]  E. Abel.  Free fatty acid oxidation in insulin resistance and obesity. , 2010, Heart and metabolism : management of the coronary patient.

[56]  S. Rosenzweig,et al.  Tumor Secretion of VEGF Induces Endothelial Cells to Suppress T cell Functions Through the Production of PGE2 , 2010, Journal of immunotherapy.

[57]  D. Hardie,et al.  Prevention of high-fat diet-induced muscular lipid accumulation in rats by α lipoic acid is not mediated by AMPK activation[S] , 2010, Journal of Lipid Research.

[58]  R. DeFronzo,et al.  Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes , 2009, Diabetes Care.

[59]  E. Barrett,et al.  Infusing lipid raises plasma free fatty acids and induces insulin resistance in muscle microvasculature. , 2009, The Journal of clinical endocrinology and metabolism.

[60]  E. Barrett,et al.  Obesity Blunts Microvascular Recruitment in Human Forearm Muscle After a Mixed Meal , 2009, Diabetes Care.

[61]  Hong Wang,et al.  The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action , 2009, Diabetologia.

[62]  Jason K. Kim.  Hyperinsulinemic-euglycemic clamp to assess insulin sensitivity in vivo. , 2009, Methods in molecular biology.

[63]  G. Steinberg,et al.  Pathways involved in lipid-induced insulin resistance in obesity , 2007 .

[64]  P. Arner,et al.  Mechanism of increased lipolysis in cancer cachexia. , 2007, Cancer research.

[65]  K. Clarke,et al.  Plasma free fatty acids and peroxisome proliferator-activated receptor alpha in the control of myocardial uncoupling protein levels. , 2005, Diabetes.

[66]  S. Kane,et al.  Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects. , 2005, Diabetes.

[67]  D. Wasserman,et al.  Control of Exercise-stimulated Muscle Glucose Uptake by GLUT4 Is Dependent on Glucose Phosphorylation Capacity in the Conscious Mouse* , 2004, Journal of Biological Chemistry.

[68]  J. Friedman,et al.  Decreased Akt kinase activity and insulin resistance in C57BL/KsJ-Leprdb/db mice. , 2000, The Journal of endocrinology.

[69]  P. Neufer,et al.  Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise. , 2000, American journal of physiology. Endocrinology and metabolism.

[70]  A. Baron,et al.  Interaction between insulin sensitivity and muscle perfusion on glucose uptake in human skeletal muscle: evidence for capillary recruitment. , 2000, Diabetes.

[71]  P. Dagnelie,et al.  Weight loss and elevated gluconeogenesis from alanine in lung cancer patients. , 2000, The American journal of clinical nutrition.

[72]  R. Henry,et al.  Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. , 1999, The Journal of clinical investigation.

[73]  A R Jayaweera,et al.  Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. , 1998, Circulation.

[74]  G. Brown,et al.  Cellular energy utilization and molecular origin of standard metabolic rate in mammals. , 1997, Physiological reviews.

[75]  C. I. Pogson,et al.  Etomoxir, sodium 2‐[6‐(4‐chlorophenoxy)hexyl]oxirane‐2‐carboxylate, inhibits triacylglycerol depletion in hepatocytes and lipolysis in adipocytes , 1997, FEBS letters.

[76]  M. Clark,et al.  Role of blood flow in regulating glucose metabolism , 1997 .

[77]  C. McArdle,et al.  The relationship between weight loss and interleukin 6 in non-small-cell lung cancer. , 1996, British Journal of Cancer.

[78]  H. Iida,et al.  Role of blood flow in regulating insulin-stimulated glucose uptake in humans. Studies using bradykinin, [15O]water, and [18F]fluoro-deoxy-glucose and positron emission tomography. , 1996, The Journal of clinical investigation.

[79]  H. Minn,et al.  In vivo effects of insulin on tumor and skeletal muscle glucose metabolism in patients with lymphoma , 1994, Cancer.

[80]  C. Lang,et al.  Impairment of insulin action on peripheral glucose uptake and hepatic glucose production in tumor-bearing rats. , 1993, American Journal of Physiology.

[81]  J. Tayek.  A review of cancer cachexia and abnormal glucose metabolism in humans with cancer. , 1992, Journal of the American College of Nutrition.

[82]  Yii-Der I. Chen,et al.  Measurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM , 1988, Diabetes.

[83]  G. Reaven,et al.  Additive Hypoglycemic Effects of Drugs That Modify Free-Fatty Acid Metabolism by Different Mechanisms in Rats With Streptozocin-Induced Diabetes , 1988, Diabetes.